Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes

Area of Science:

• Biomedical Engineering
• Hematology
• Materials Science

Background:

• Initial artificial red blood cell (RBC) substitutes, including perfluorocarbon (PFC) emulsions and hemoglobin-based oxygen carriers (HBOCs), faced challenges.
• These challenges included issues with biocompatibility and efficacy in oxygen delivery.
• There is a persistent clinical need for safe and effective blood substitutes.

Purpose of the Study:

• To review recent advancements in the development of artificial red blood cell (RBC) substitutes.
• To highlight lessons learned from earlier generations of blood substitutes.
• To explore novel approaches and future directions for improved blood substitute design.

Main Methods:

• Review of literature on perfluorocarbon (PFC) emulsions and hemoglobin-based oxygen carriers (HBOCs).
• Analysis of emerging technologies: oxygen-containing microparticles, nanoparticles, and stem cell-derived RBCs.
• Emphasis on evaluating improvements in biocompatibility and oxygen transport capabilities.

Main Results:

• Novel oxygen-carrying micro/nanoparticles demonstrate enhanced biocompatibility.
• Stem cell-derived RBC products show potential for improved oxygen delivery.
• Recent developments address limitations of earlier PFC and HBOC blood substitutes.

Conclusions:

• Significant progress has been made in developing advanced artificial red blood cell substitutes.
• New materials and cell-based strategies offer promising alternatives to traditional blood products.
• Future rational design will focus on addressing unmet clinical needs for blood transfusion alternatives.